%0 Journal Article
%T Cilnidipine and Telmisartan Similarly Improves Vascular Damage in Hypertensive Patients
%A Yuki Kaneshiro
%A Atsuhiro Ichihara
%A Mariyo Sakoda
%A Asako Kurauchi
%J Clinical Medicine : Cardiology
%D 2007
%I 
%X This study was designed to compare the effects of 12-month blood pressure (BP) control using cilnidipine and telmisartan on vascular damage in untreated hypertensive patients. One hundred patients were randomly assigned to either a cilnidipine group or a telmisartan group. The extent of vascular damage was assessed before and after treatment by measuring urinary albumin excretion (UAE), pulse wave velocity (PWV), and intima-media thickness (IMT) of the carotid arteries in each patient. Both drugs similarly decreased BP without altering plasma markers for oxidative stress or inflammation. Both UAE and PWV were significantly improved in both groups, but IMT was significantly reduced only in the cilnidipine group. Multiple regression analyses suggested that the UAE may have decreased as a result of a reduction in intraglomerular pressure caused by telmisartan or by efferent arteriolar dilation caused by cilnidipine. In addition, the PWV may have decreased as a result of the improvement in lipid metabolism caused by telmisartan or the reduction in plasma levels of aldosterone caused by cilnidipine. However, the analyses could not identify any definitive causal relationships or suggest the mechanism responsible for the improvement in IMT caused by cilnidipine. Thus, telmisartan and cilnidipine have unique properties for inhibiting vascular complications.
%K ambulatory blood pressure
%K aldosterone
%K intima-media thickness
%K pulse wave velocity
%K urinary albumin excretion
%U http://la-press.com/article.php?article_id=379